Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 19

    1.

    Bilateral Epibulbar Xanthomas-A Case Report.

    Satchi K, Loughnan MS, McKelvie PA, McNab AA.

    Cornea. 2009 Sep 16. [Epub ahead of print]PMID: 19770720 [PubMed - as supplied by publisher]Related articles

    2.

    Prevalence of Orbscan II corneal abnormalities in relatives of patients with keratoconus.

    Steele TM, Fabinyi DC, Couper TA, Loughnan MS.

    Clin Experiment Ophthalmol. 2008 Dec;36(9):824-30.PMID: 19278476 [PubMed - indexed for MEDLINE]Related articles

    3.

    Microbial keratitis associated with extended wear of silicone hydrogel contact lenses.

    Lim L, Loughnan MS, Sullivan LJ.

    Br J Ophthalmol. 2002 Mar;86(3):355-7. No abstract available. PMID: 11864902 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Phototherapeutic keratectomy re-treatment for recurrent corneal erosion syndrome.

    Maini R, Loughnan MS.

    Br J Ophthalmol. 2002 Mar;86(3):270-2.PMID: 11864879 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Understanding keratoconus.

    Loughnan MS, Snibson GR.

    Clin Experiment Ophthalmol. 2001 Dec;29(6):339. No abstract available. PMID: 11778800 [PubMed - indexed for MEDLINE]Related articles

    6.

    A comparison of different depth ablations in the treatment of painful bullous keratopathy with phototherapeutic keratectomy.

    Maini R, Sullivan L, Snibson GR, Taylor HR, Loughnan MS.

    Br J Ophthalmol. 2001 Aug;85(8):912-5.PMID: 11466243 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Mechanical methods in refractive corneal surgery.

    Loughnan MS, Robinson D, Sullivan L.

    Curr Opin Ophthalmol. 1996 Aug;7(4):41-6. Review.PMID: 10163638 [PubMed - indexed for MEDLINE]Related articles

    8.

    Thalidomide is an inhibitor of angiogenesis.

    D'Amato RJ, Loughnan MS, Flynn E, Folkman J.

    Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):4082-5.PMID: 7513432 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    A new codon 15 rhodopsin gene mutation in autosomal dominant retinitis pigmentosa is associated with sectorial disease.

    Sullivan LJ, Makris GS, Dickinson P, Mulhall LE, Forrest S, Cotton RG, Loughnan MS.

    Arch Ophthalmol. 1993 Nov;111(11):1512-7.PMID: 8240107 [PubMed - indexed for MEDLINE]Related articles

    10.

    Treatment of a massive orbital-capillary hemangioma with interferon alfa-2b: short-term results.

    Loughnan MS, Elder J, Kemp A.

    Arch Ophthalmol. 1992 Oct;110(10):1366-7. No abstract available. PMID: 1417530 [PubMed - indexed for MEDLINE]Related articles

    11.

    Treatment of subfoveal choroidal neovascular membranes with systemic interferon-alpha 2a.

    Loughnan MS, Heriot WJ, O'Day J.

    Aust N Z J Ophthalmol. 1992 Aug;20(3):173-5.PMID: 1280447 [PubMed - indexed for MEDLINE]Related articles

    12.

    Neovascularisation: has the angiogenic factor already been found?

    Loughnan MS.

    Aust N Z J Ophthalmol. 1991 Feb;19(1):65-9. Review.PMID: 1710135 [PubMed - indexed for MEDLINE]Related articles

    13.

    Detection by immunofluorescence of surface molecules present in low copy numbers. High sensitivity staining and calibration of flow cytometer.

    Zola H, Neoh SH, Mantzioris BX, Webster J, Loughnan MS.

    J Immunol Methods. 1990 Dec 31;135(1-2):247-55.PMID: 1703189 [PubMed - indexed for MEDLINE]Related articles

    14.

    A regulatory role for the soluble IL-2 receptor via competition with the p75 cell-surface form of the receptor for IL-2.

    Loughnan MS, Nossal GJ.

    J Mol Cell Immunol. 1990;4(6):307-15; discussion 316.PMID: 2080985 [PubMed - indexed for MEDLINE]Related articles

    15.

    Interleukins 4 and 5 control expression of IL-2 receptor on murine B cells through independent induction of its two chains.

    Loughnan MS, Nossal GJ.

    Nature. 1989 Jul 6;340(6228):76-9.PMID: 2786996 [PubMed - indexed for MEDLINE]Related articles

    16.

    Anti-IL-2 receptor monoclonal antibody AMT-13 increases soluble IL-2 receptor levels in vivo.

    Burkhardt K, Mandel TE, Diamantstein T, Loughnan MS.

    Immunology. 1989 Feb;66(2):183-9.PMID: 2647626 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Immunosuppressive effect of the anti-IL-2-receptor monoclonal antibody, AMT-13, on organ-cultured fetal pancreas allograft survival.

    Burkhardt K, Loughnan MS, Diamantstein T, Mandel TE.

    Transplantation. 1988 Nov;46(5):726-31.PMID: 3057695 [PubMed - indexed for MEDLINE]Related articles

    18.

    Soluble interleukin 2 receptors are released from the cell surface of normal murine B lymphocytes stimulated with interleukin 5.

    Loughnan MS, Sanderson CJ, Nossal GJ.

    Proc Natl Acad Sci U S A. 1988 May;85(9):3115-9.PMID: 3129727 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    T-cell-replacing factor (interleukin 5) induces expression of interleukin 2 receptors on murine splenic B cells.

    Loughnan MS, Takatsu K, Harada N, Nossal GJ.

    Proc Natl Acad Sci U S A. 1987 Aug;84(15):5399-403.PMID: 3110787 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...